Because prandial insulin is often dosed proportionally to carbohydrate intake in type 1 diabetes, the RCD offers a means to decrease the total daily dose of insulin (TDDinsulin), potentially mitigating insulin resistance and endothelial dysfunction associated with iatrogenic peripheral hyperinsulinemia. The gene discussed is INS; the disease is endothelial dysfunction.